Engrave Wealth Partners’s Eli Lilly LLY Stock Holding History

Engrave Wealth Partners’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$441K	Buy	757 +273	+56%	+$159K	0.13%	52
2023 Q3	$260K	Hold	484	–	–	0.08%	56
2023 Q2	$227K	Buy	+484	New	+$203K	0.07%	60
2020 Q3	–	Sell	-464	Closed	-$76K	–	263
2020 Q2	$76K	Hold	464	–	–	0.07%	86
2020 Q1	$64K	Hold	464	–	–	0.08%	79
2019 Q4	$60K	Buy	+464	New	+$53.8K	0.06%	117

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Engrave Wealth Partners's LLY Position: Q4 2023 in Review

Engrave Wealth Partners increased its Eli Lilly (LLY) stake by 56% in Q4 2023, buying an estimated $159K and bringing the position to 757 shares worth $441K. The position accounts for 0.13% of the portfolio, ranked #52.

Engrave Wealth Partners first reported a position in LLY in Q4 2019 and has held it in 6 quarters since. 3,276 funds tracked by Wall St. Rank hold LLY as of Q4 2023.

Engrave Wealth Partners held 757 shares of Eli Lilly worth $441K as of Q4 2023.
Engrave Wealth Partners bought 273 Eli Lilly shares in Q4 2023, an estimated $159K.
Eli Lilly made up 0.13% of Engrave Wealth Partners's portfolio in Q4 2023, its #52 holding.
Engrave Wealth Partners first reported a position in Eli Lilly in Q4 2019 and has held it in 6 quarters since.
3,276 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2023.

Based on Engrave Wealth Partners's 13F filing for Q4 2023, filed 16 Jan 2024.